Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

5.86
Delayed Data
As of 4:00pm ET
 -0.31 / -5.02%
Today’s Change
1.51
Today|||52-Week Range
8.84
+187.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues7.7M13.8M28.5M39.0M
 
 
 
 
 
Depreciation And Amortization----1.5M1.4M
 
 
 
 
Operating ExpensesGross Income----------
General Expenses42.4M42.2M39.5M42.7M
 
 
 
 
 
Other Operating Expenses4.1M301.0K0.000.00
 
 
 
Research And Development32.9M33.7M32.9M35.3M
 
 
 
 
 
Total Operating Expenses9.5M8.5M41.0M44.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.8M-28.6M-12.5M-5.1M
 
 
 
 
 
Extraordinary Charge-----386.0K--
 
 
Interest Expense On Debt6.2M4.7M4.7M4.6M
 
 
 
 
 
Other Expenses275.0K-758.0K134.0K751.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-44.7M-34.2M-17.3M-8.9M
 
 
 
 
 
Net Income-44.7M-34.2M-17.3M-8.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS87.1M87.1M87.2M87.2M
 
 
 
 
 
Shares To Calculate EPS Diluted87.1M87.1M87.2M87.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.51-$0.39-$0.20-$0.10
 
 
 
 
 
EPS Diluted-$0.51-$0.39-$0.20-$0.10